Cortendo Enters Into Agreements to Acquire Aspireo Pharmaceuticals’ Somatoprim (DG3173) and In-License Antisense Therapeutics’ ATL1103 Cortendo Expands Investor Base Through New Private Placement May 15, 2015 – Göteborg, Sweden and Trevose, Pa., USA –...
